Hill-Rom Holdings, Inc. (NYSE:HRC) declared a quarterly dividend on Tuesday, July 16th, Zacks reports. Shareholders of record on Friday, September 20th will be given a dividend of 0.21 per share by the medical technology company on Monday, September 30th. This represents a $0.84 dividend on an annualized basis and a yield of 0.81%. The ex-dividend date is Thursday, September 19th.

Hill-Rom has raised its dividend payment by an average of 7.7% per year over the last three years and has increased its dividend annually for the last 8 consecutive years. Hill-Rom has a payout ratio of 18.1% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Hill-Rom to earn $5.50 per share next year, which means the company should continue to be able to cover its $0.84 annual dividend with an expected future payout ratio of 15.3%.

NYSE HRC opened at $103.61 on Tuesday. The firm’s 50-day moving average is $105.67 and its two-hundred day moving average is $103.45. Hill-Rom has a 12 month low of $81.82 and a 12 month high of $109.18. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.51 and a quick ratio of 1.14. The stock has a market capitalization of $7.02 billion, a P/E ratio of 21.81, a PEG ratio of 2.08 and a beta of 0.87.

Hill-Rom (NYSE:HRC) last posted its earnings results on Friday, August 2nd. The medical technology company reported $1.23 EPS for the quarter, beating the Zacks’ consensus estimate of $1.21 by $0.02. Hill-Rom had a net margin of 7.45% and a return on equity of 21.26%. The company had revenue of $726.80 million for the quarter, compared to analysts’ expectations of $718.08 million. During the same quarter in the prior year, the company posted $1.15 earnings per share. Hill-Rom’s revenue for the quarter was up 2.6% compared to the same quarter last year. As a group, analysts anticipate that Hill-Rom will post 5.05 EPS for the current year.

In other Hill-Rom news, SVP Paul Sherwood Johnson sold 6,470 shares of the business’s stock in a transaction dated Wednesday, August 14th. The shares were sold at an average price of $104.26, for a total transaction of $674,562.20. Following the sale, the senior vice president now directly owns 8,215 shares in the company, valued at $856,495.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Deborah Rasin sold 5,500 shares of the business’s stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $103.00, for a total transaction of $566,500.00. Following the sale, the senior vice president now owns 20,939 shares in the company, valued at $2,156,717. The disclosure for this sale can be found here. 0.73% of the stock is owned by corporate insiders.

HRC has been the topic of a number of recent analyst reports. KeyCorp upped their target price on shares of Hill-Rom from $114.00 to $125.00 and gave the company an “overweight” rating in a research report on Monday, August 5th. Needham & Company LLC reaffirmed a “buy” rating and issued a $125.00 target price on shares of Hill-Rom in a research report on Tuesday, August 6th. ValuEngine cut shares of Hill-Rom from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Zacks Investment Research raised shares of Hill-Rom from a “hold” rating to a “buy” rating and set a $103.00 target price on the stock in a research report on Thursday, June 6th. Finally, Barclays boosted their price target on shares of Hill-Rom from $108.00 to $116.00 and gave the stock an “equal weight” rating in a research note on Tuesday, August 6th. Three equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $112.43.

Hill-Rom Company Profile

Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.

Read More: What is the Current Ratio?

Dividend History for Hill-Rom (NYSE:HRC)

Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.